Results from the PROMISE clinical trial confirmed what many cardiologists and radiologists have long suspected to be true: Coronary computed tomographic angiography (coronary CTA) is extraordinarily effective in accurately diagnosing patients with low to moderate chest pain.
July 8, 2014 — Humana Inc. announced earlier this year an expanded coverage policy for cardiac CT (computed tomography). Many of the new Humana indications have long been advocated for by the Society of Cardiovascular Computed Tomography (SCCT) and described in the model local coverage determination policy (LCD) developed by the organization.